Wilson disease: New insights into pathogenesis, diagnosis, and future therapy
Wilson disease is caused by disease-specific mutations of the copper transporting ATPase, ATP7B. The diagnosis is established by clinical and biochemical means, though advances in molecular diagnostics will someday permit de novo diagnosis. The patient may present with hepatic, neurologic, or psychiatric symptoms, or a combination of these. Both environmental and extragenic effects contribute to the varied phenotypic presentations of this disease. Patients can be treated effectively with chelating agents or zinc salts, or with liver transplantation. Liver cell transplant and gene therapy offer potential cures for this disorder, but at present only data from preclinical studies on animal models are available. Future advances in immunotolerization and gene therapy will likely enable human trials for treatment of this disorder and other genetic disorders of hepatic metabolism.
KeywordsWilson Disease Copper Metabolism Menkes Disease ATP7B Gene Hepatic Copper
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 1.Bowcock AM, Farrer LA, Hebert JM, et al.: Eight closely linked loci place the Wilson disease locus within 13q14-q21. Am J Hum Genet 1988, 43:664–674. Initial studies showing localization to chromosome 13 that set the stage for identification of the gene for Wilson disease (see [2-4]).PubMedGoogle Scholar
- 5.Schilsky ML, Stockert RJ, Sternlieb I: Pleiotropic effect of LEC mutation: a rodent model of Wilson’s disease. Am J Physiol. 1994, 266:G907-G913. These studies showed that the defect in the LEC rat is in biliary copper excretion, and not a failure of lysosomal delivery to bile. The dual function of the ATP7B gene to transport copper into endosomal/lysosomal vesicles and to Golgi for copper incorporation into ceruloplasmin was demonstrated.PubMedGoogle Scholar
- 6.Huster D, Hoppert M, Lutsenko S, et al.: Defective cellular localization of mutant ATP7B in Wilson’s disease patients and hepatoma cell lines. Gastroenterology 2003, 124:335–345. The failure of some disease-specific mutants to localize properly to the trans-Golgi was demonstrated by transfection of liver cell lines. These data show the importance of proper cellular localization for ATP7B function.PubMedCrossRefGoogle Scholar
- 12.Schiefermeier M, Kollegger H, Madl C, et al.: The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson’s disease. Brain 2000, 123:585–590. First demonstration of an extragenic effect on the phenotypic expression of Wilson disease.PubMedCrossRefGoogle Scholar
- 21.Stuehler B, Reichert J, Stremmel W, Schaefer M: Analysis of the human homologue of the canine copper toxicosis gene MURR1 in Wilson disease patients. J Mol Med 2004, 82:629–634. These studies suggest that alterations in other proteins in the copper metabolic pathway may affect the phenotypic expression of Wilson disease. This concept is similar to that now being developed for iron overload disorders, where there are several different gene products that may act in concert to influence phenotypic expression of disease.PubMedCrossRefGoogle Scholar
- 22.Yoshida Y, Tokusashi Y, Lee GH, Ogawa K: Intrahepatic transplantation of normal hepatocytes prevents Wilson’s disease in Long-Evans cinnamon rats. Gastroenterology 1996, 111:1654–1660. First study showing that successful transplantation of normal liver cells into LEC rats may prevent copper toxicosis.PubMedCrossRefGoogle Scholar
- 23.Irani AN, Malhi H, Slehria S, et al.: Correction of liver disease following transplantation of normal rat hepatocytes into Long-Evans Cinnamon rats modeling Wilson’s disease. Mol Ther 2001, 3:302–309. Studies extending those by Yoshida et al.  demonstrating the need for at least 30% cell replacement to achieve prevention of copper toxicosis. Restoration of biliary copper excretion and holoceruloplasmin secretion were also demonstrated along with reduction in hepatic copper and prevention of cellular injury in rats successfully transplanted with normal rat hepatocytes.PubMedCrossRefGoogle Scholar
- 24.Malhi H, Irani AN, Volenberg I, et al.: Early cell transplantation in LEC rats modeling Wilson’s disease eliminates hepatic copper with reversal of liver disease. Gastroenterology 2002, 122:438–447. The ability to transplant the normal liver cells into young LEC rats prevented the need for alkaloids and partial hepatectomy to achieve selective repopulation with transplanted cells.PubMedCrossRefGoogle Scholar